Higher gamma-glutamyl transferase levels predict greater systemic sclerosis risk

Patients with higher levels of gamma-glutamyl transferase, and particularly men, demonstrate a significantly higher risk for systemic sclerosis, according to data published in Nature Scientific Reports.
“Early detection of SSc and timely implementation of treatment are important for better outcomes,” Oh Chan Kwon, MD, of Yonsei University College of Medicine, in Seoul, South Korea, and colleagues wrote. “Identification and close monitoring of individuals who are at a high risk of developing SSc could lead to earlier diagnosis and treatment.
“Given its pro-oxidant

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart